https://www.selleckchem.com/pr....oducts/pf-07104091.h
1 ± 0.3 (p=0.014). In patients with previous RV pacing, HBP resulted in a significant decrease in QRS duration 167.1 ± 14.3ms versus 118.3 ± 13.9ms (p0.0001). In de novo implants, HBP resulted in increases in QRS duration compared with baseline 111.1 ± 19.4ms versus 91.0 ± 4.8ms (p=0.016). Other parameters exhibited no statistically significant differences. During follow-up, 2 patients required lead revision due to elevated pacing thresholds. HBP seems to be safe and effective, with improvement in clinical outcomes in patients w
Like
Comment
Share
